ProQuest Investments
59
35M
35
2.36
9
0.41
25
- Stages of investment
- Areas of investment
Summary
ProQuest Investments is the famous VC, which was founded in 1998. The venture was found in North America in United States. The main department of described VC is located in the Princeton.
The overall number of key employees were 1.
We can highlight the next thriving fund investment areas, such as Medical, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Pharmion, ReVision Optics, Aerovance. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the ProQuest Investments, startups are often financed by Domain Associates, Canaan Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, New Enterprise Associates, Canaan Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Domain Associates, Canaan Partners.
The top activity for fund was in 2009. The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from ProQuest Investments is 10-50 millions dollars. The top amount of exits for fund were in 2014. Opposing the other organizations, this ProQuest Investments works on 11 percentage points more the average amount of lead investments. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 59
- Lead investments
- 9
- Exits
- 25
- Rounds per year
- 2.36
- Follow on index
- 0.41
- Investments by industry
- Biotechnology (53)
- Health Care (46)
- Medical (22)
- Therapeutics (21)
- Pharmaceutical (21) Show 13 more
- Investments by region
-
- United States (52)
- Canada (3)
- Switzerland (3)
- United Kingdom (1)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 173M
- Group Appearance index
- 0.98
- Avg. company exit year
- 8
- Avg. multiplicator
- 2.58
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mersana Therapeutics | 31 Jul 2012 | Biotechnology, Drug Discovery, Health Care, Medical, Therapeutics | Early Stage Venture | 27M | United States, Massachusetts, Cambridge |
| Predictive Biosciences | 18 Jun 2010 | Biotechnology, Health Diagnostics, Medical Device | Late Stage Venture | 25M | United States, Massachusetts |
| REPP | 13 Feb 2013 | Internet, Identity Management | Seed | 95K | United States, Ohio, Cincinnati |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.